Skip to main content
. Author manuscript; available in PMC: 2023 Jul 24.
Published in final edited form as: J Neurol Sci. 2022 Feb 23;435:120198. doi: 10.1016/j.jns.2022.120198

Fig. 1.

Fig. 1.

Climbing fiber synaptic pathology in ET. (A) In a control subject, climbing fiber synapses, as visualized by the vesicular glutamate transporter type 2 immunohistochemistry, usually do not extend to the outer 20% of the molecular layer (dash line), which is the parallel fiber synaptic territory. (B) In a ET patient, climbing fiber synapses abnormally extend to the parallel fiber synaptic territory (arrows).